cryptococcosis potentially fatal fungal infection mainly lungs presenting pneumonia brain appears cough difficulty breathing chest pain fever seen lungs brain infected symptoms include headache fever neck pain nausea vomiting light sensitivity confusion changes also affect parts body including skin may appear several fluidfilled nodules dead caused fungi cryptococcus neoformans less commonly cryptococcus gattii acquired breathing spores fungi found around world soil decaying wood pigeon droppings hollows species whereas c neoformans generally infects people hivaids immunosuppressant drugs usually affect fit healthy people c gattii found parts canada us breathed dried yeast cells colonize lungs either cleared immune cells lie dormant cause infection diagnosis isolating cryptococcus sample affected tissue direct observation fungus using staining body cultured cerebrospinal fluid sputum skin treatment fluconazole amphotericin data estimated almost one million cases cryptococcal meningitis occurred worldwide annually occurred subsaharan africa per year cryptococcosis rare saw increase atrisk groups people organ transplant immunosuppressant number cases escalated occurring people pigeon breeders otherwise people spend significant time pigeons known high incidence cryptococcal infections including pcc due cryptococcus association pigeon cryptococcus generally classified according acquired typically begins lungs spreading parts body particularly brain nervous skin type less cough shortness breath chest pain fever seen lungs infected appearing like may also feeling brain infected symptoms include headache fever neck pain nausea vomiting light sensitivity confusion changes also affect parts body including skin eyes bones skin may appear several fluidfilled nodules dead depending site infection features may include loss vision blurred vision inability move eye memory symptom onset often sudden lungs infected gradual several weeks central nervous system cryptococcosis common opportunistic infection aids particularly common among people living aids africa conditions pose increased risk include certain malignancies lymphoma liver cirrhosis organ transplants longterm corticosteroid distribution worldwide prevalence cryptococcosis increasing past years many reasons including increase incidence aids expanded use immunosuppressive humans c neoformans chiefly infects skin lungs central nervous system causing less commonly may affect organs eye primary cutaneous cryptococcosis pcc distinct clinical diagnosis separate secondary cutaneous cryptococcosis spread systematic infection males likely develop infection study showed sex bias may due growth hormone produced c neoformans called gibberellic acid ga upregulated upper limbs account majority infections isolates found pcc include cryptococcus neoformans common cryptococcus gattii cryptococcus laurentii prognosis pcc generally good outside disseminated morphologic description lesions show umbilicated papules nodules violaceous plaques mimic cutaneous diseases like molluscum contagiosum kaposis sarcoma lesions may present months signs system infection patients cryptococcus c neoformans c gattii plays common role pulmonary invasive mycosis seen adults hiv immunocompromised also affects healthy adults much lower frequency severity healthy hosts may mild immunecompetent hosts may seek require treatment careful observation may cryptococcal pneumonia potential disseminate central nervous system cns especially immunocompromised pulmonary cryptococcosis worldwide distribution commonly underdiagnosed due limitations diagnostic capabilities since pulmonary nodules common radiological feature clinically radiologically mimic lung cancer tb pulmonary mycoses sensitivity cultures cryptococcal crag antigen lateral flow device serum rarely positive absence disseminated moreover pulmonary cryptococcosis worsen prognosis cryptococcal cryptococcal meningitis infection meninges tissue covering brain believed result dissemination fungus either observed unappreciated pulmonary infection often also silent dissemination throughout brain meningitis present people defects cellmediated immunity example people aids especially susceptible disseminated cryptococcosis cryptococcosis often fatal even treated estimated threemonth casefatality rate highincome regions lowmiddleincome regions subsaharan africa globally approximately annual cases deaths within three months although c neoformans infection commonly occurs opportunistic infection immunocompromised people living aids c gattii often infects immunocompetent people cryptococcus c neoformans c gattii dominant etiologic agent meningitis adults hiv considered emerging disease healthy though rate infection clearly higher immunocompromised individuals studies suggest higher mortality rate patients nonhiv cryptococcal meningitis secondary role tcell mediated reaction cells proven roles defense cryptococcus also contribute clinical deterioration due inflammatory dependent infectious syndrome symptoms include fever fatigue dry cough headache blurred vision symptom onset often subacute progressively worsened several weeks two common presentations meningitis infection around brain pulmonary lung person found cryptococcosis site outside central nervous system eg pulmonary cryptococcosis lumbar puncture indicated evaluate cerebrospinal fluid csf evidence cryptococcal meningitis even signs symptoms cns disease detection cryptococcal antigen capsular material culture csf sputum urine provides definitive blood cultures may positive heavy infections india ink csf traditional microscopic method although sensitivity poor early infection may miss patients culturepositive cryptococcal unusual morphological forms rarely cryptococcal antigen cerebrospinal fluid best test diagnosis cryptococcal meningitis terms apart conventional methods detection like direct microscopy culture rapid diagnostic methods detect cryptococcal antigen latex agglutination test lateral flow immunochromatographic assay lfa enzyme immunoassay eia new cryptococcal antigen lfa fda approved july polymerase chain reaction pcr used tissue specimens cryptococcosis rarely occur nonimmunosuppressed people particularly cryptococcus gattiicitation needed cryptococcosis subacute infection prolonged subclinical phase lasting weeks months persons hivaids onset symptomatic meningitis subsaharan africa prevalence rates detectable cryptococcal antigen peripheral blood often persons counts lower cryptococcal antigen screen preemptive treatment fluconazole cost saving healthcare system avoiding cryptococcal world health organization recommends cryptococcal antigen screening hivinfected persons entering care undetected subclinical cryptococcal preemptively treated antifungal therapy often go develop cryptococcal meningitis despite receiving hiv cryptococcosis accounts mortality initiating hiv therapy africa effective preemptive treatment unknown current recommendations dose duration based expert opinion screening united states controversial official guidelines recommending screening despite costeffectiveness us cryptococcal antigen prevalence antifungal prophylaxis fluconazole itraconazole reduces risk contracting cryptococcosis low cell count high risk developing disease setting cryptococcal antigen screening tests treatment options persons without hivinfection well studied intravenous amphotericin b combined flucytosine mouth recommended initial treatment induction people living aids often greater burden disease higher mortality recommended therapy amphotericin b flucytosine flucytosine available many low middle income countries fluconazole used amphotericinbased induction therapy much greater microbiologic activity fluconazole monotherapy better survival based systematic review existing data costeffective induction treatment resourcelimited settings appears one week amphotericin b coupled highdose initial induction treatment typical consolidation therapy oral fluconazole least weeks used secondary prophylaxis fluconazole decision start treatment hiv appears different opportunistic infections large multisite trial supports deferring art weeks overall preferable better survival earlier art initiation weeks cochrane review also supports delayed starting treatment cryptococcosis starts improving antifungal immune reconstitution inflammatory syndrome iris described normal immune function meningitis caused c gattii c grubii increasing inflammation cause brain injury data estimated almost one million cases cryptococcal meningitis occurred worldwide annually occurred subsaharan africa per year cryptococcosis also seen cats occasionally dogs common deep fungal disease cats usually leading chronic infection nose sinuses skin ulcers cats may develop bump bridge nose local tissue inflammation associated felv infection cats cryptococcosis common dogs cats cattle sheep goats horses wild animals birds also infected soil fowl manure pigeon droppings among sources httpsenwikipediaorgwikicryptococcosis